Browsing by Author "Brozek, JL"

Now showing 1 - 4 of 4
  • No Thumbnail Available
    Item
    ARIA pharmacy 2018 Allergic rhinitis care pathways for community pharmacy AIRWAYS ICPs initiative (European Innovation Partnership on Active and Healthy Ageing, DG CONNECT and DG Sante) \nPOLLAR (Impact of Air POLLution on Asthma and Rhinitis)\nGARD Demonstration project
    Bosnic-Anticevich, S; Costa, E; Menditto, E; Lourenço, O; Novellino, E; Bialek, S; Briedis, V; Buonaiuto, R; Chrystyn, H; Cvetkovski, B; Di Capua, S; Kritikos, V; Mair, A; Orlando, V; Paulino, E; Salimäki, J; Söderlund, R; Tan, R; Williams, DM; Wroczynski, P; Agache, I; Ansotegui, IJ; Anto, JM; Bedbrook, A; Bachert, C; Bewick, M; Bindslev-Jensen, C; Brozek, JL; Canonica, GW; Cardona, V; Carr, W; Casale, TB; Chavannes, NH; de Sousa, JC; Cruz, AA; Czarlewski, W; De Carlo, G; Demoly, P; Devillier, P; Dykewicz, MS; Gaga, M; El-Gamal, Y; Fonseca, J; Fokkens, WJ; Guzmán, MA; Haahtela, T; Hellings, PW; Illario, M; Ivancevich, JC; Just, J; Kaidashev, I; Khaitov, M; Khaltaev, N; Keil, T; Klimek, L; Kowalski, ML; Kuna, P; Kvedariene, V; Larenas-Linnemann, DE; Laune, D; Le, LTT; Carlsen, KCL; Mahboub, B; Maier, D; Malva, J; Manning, PJ; Morais-Almeida, M; Mösges, R; Mullol, J; Münter, L; Murray, R; Naclerio, R; Nannazova-Baranove, L; Nekann, K; Nyembue, TD; Okubo, K; O'Hehir, RE; Ohta, K; Okamoto, Y; Onorato, GL; Palkonen, S; Panzner, P; Papadopoulos, NG; Park, HS; Pawankar, R; Pfaar, O; Phillips, J; Plavec, D; Popov, TA; Potter, PC; Prokopakis, EP; Roller-Wirnsberger, RE; Rottenn, M; Ryan, D; Sannolinski, B; Sanchez-Borges, M; Schunemann, HJ; Sheikh, A; Sisul, JC; Somekh, D; Stellato, C; To, T; Todo-Bonn, AM; Tonnazic, PV; Toppila-Salmi, S; Valero, A; Valiulis, A; Valovirta, E; Ventura, MT; Wagennnann, M; Wallace, D; Wasernnan, S; Wickman, M; Yiallouros, PK; Yorgancioglu, A; Yusuf, OM; Zar, HJ; Zernotti, ME; Zhang, L; Zidarn, M; Zuberbier, T; Bousquet, J
    Pharmacists are trusted health care professionals. Many patients use over-the-counter (OTC) medications and are seen by pharmacists who are the initial point of contact for allergic rhinitis management in most countries. The role of pharmacists in integrated care pathways (ICPs) for allergic diseases is important. This paper builds on existing studies and provides tools intended to help pharmacists provide optimal advice/interventions/strategies to patients with rhinitis. The Allergic Rhinitis and its Impact on Asthma (ARIA)-pharmacy ICP includes a diagnostic questionnaire specifically focusing attention on key symptoms and markers of the disease, a systematic Diagnosis Guide (including differential diagnoses), and a simple flowchart with proposed treatment for rhinitis and asthma multimorbidity. Key prompts for referral within the ICP are included. The use of technology is critical to enhance the management of allergic rhinitis. However, the ARIA-pharmacy ICP should be adapted to local healthcare environments/situations as regional (national) differences exist in pharmacy care.
  • No Thumbnail Available
    Item
    Severe Chronic Allergic (and Related) Diseases: A Uniform Approach - A MeDALL - GA2LEN - ARIA Position Paper
    Bousquet, J; Anto, JM; Demoly, P; Schünemann, HJ; Togias, A; Akdis, M; Auffray, C; Bachert, C; Bieber, T; Bousquet, PJ; Carlsen, KH; Casale, TB; Cruz, AA; Keil, T; Carlsen, KCL; Maurer, M; Ohta, K; Papadopoulos, NG; Rodriguez, MR; Samolinski, B; Agache, I; Andrianarisoa, A; Ang, CS; Annesi-Maesano, I; Ballester, F; Baena-Cagnani, CE; Basagaña, X; Bateman, ED; Bel, EH; Bedbrook, A; Beghé, B; Beji, M; Ben Kheder, A; Benet, M; Bennoor, KS; Bergmann, KC; Berrissoul, F; Jensen, CB; Bleecker, ER; Bonini, S; Boner, AL; Boulet, LP; Brightling, CE; Brozek, JL; Bush, A; Busse, WW; Camargos, PAM; Canonica, GW; Carr, W; Cesario, A; Chen, YZ; Chiriac, AM; Costa, DJ; Cox, L; Custovic, A; Dahl, R; Darsow, U; Didi, T; Dolen, WK; Douagui, H; Dubakiene, R; El-Meziane, A; Fonseca, JA; Fokkens, WJ; Fthenou, E; Gamkrelidze, A; Garcia-Aymerich, J; van Wijk, RG; Gimeno-Santos, E; Guerra, S; Haahtela, T; Haddad, H; Hellings, PW; Hellquist-Dahl, B; Hohmann, C; Howarth, P; Hourihane, JO; Humbert, M; Jacquemin, B; Just, J; Kalayci, O; Kaliner, MA; Kauffmann, F; Kerkhof, M; Khayat, G; N'Goran, BK; Kogevinas, M; Koppelman, GH; Kowalski, ML; Kull, I; Kuna, P; Larenas, D; Lavi, I; Le, LT; Lieberman, P; Lipworth, B; Mahboub, B; Makela, MJ; Martin, F; Martinez, FD; Marshall, GD; Mazon, A; Melen, E; Meltzer, EO; Mihaltan, F; Mohammad, Y; Mohammadi, A; Momas, I; Morais-Almeida, M; Mullol, J; Muraro, A; Naclerio, R; Nafti, S; Namazova-Baranova, L; Nawijn, MC; Nyembue, TD; Oddie, S; O'Hehir, RE; Okamoto, Y; Orru, MP; Ozdemir, C; Ouedraogo, GS; Palkonen, S; Panzner, P; Passalacqua, G; Pawankar, R; Pigearias, B; Pin, I; Pinart, M; Pison, C; Popov, TA; Porta, D; Postma, DS; Price, D; Rabe, KF; Ratomaharo, J; Reitamo, S; Rezagui, D; Ring, J; Roberts, R; Roca, J; Rogala, B; Romano, A; Rosado-Pinto, J; Ryan, D; Sanchez-Borges, M; Scadding, GK; Sheikh, A; Simons, FER; Siroux, V; Schmid-Grendelmeier, PD; Smit, HA; Sooronbaev, T; Stein, RT; Sterk, PJ; Sunyer, J; Terreehorst, I; Toskala, E; Tremblay, Y; Valenta, R; Valeyre, D; Vandenplas, O; van Weel, C; Vassilaki, M; Varraso, R; Viegi, G; Wang, DY; Wickman, M; Williams, D; Wöhrl, S; Wright, J; Yorgancioglu, A; Yusuf, OM; Zar, HJ; Zernotti, ME; Zidarn, M; Zhong, N; Zuberbier, T
    Concepts of disease severity, activity, control and responsiveness to treatment are linked but different. Severity refers to the loss of function of the organs induced by the disease process or to the occurrence of severe acute exacerbations. Severity may vary over time and needs regular follow-up. Control is the degree to which therapy goals are currently met. These concepts have evolved over time for asthma in guidelines, task forces or consensus meetings. The aim of this paper is to generalize the approach of the uniform definition of severe asthma presented to WHO for chronic allergic and associated diseases (rhinitis, chronic rhinosinusitis, chronic urticaria and atopic dermatitis) in order to have a uniform definition of severity, control and risk, usable in most situations. It is based on the appropriate diagnosis, availability and accessibility of treatments, treatment responsiveness and associated factors such as comorbidities and risk factors. This uniform definition will allow a better definition of the phenotypes of severe allergic (and related) diseases for clinical practice, research (including epidemiology), public health purposes, education and the discovery of novel therapies. Copyright (C) 2012 S. Karger AG, Basel
  • No Thumbnail Available
    Item
    Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs
    Bousquet, J; Schünemann, HJ; Samolinski, B; Demoly, P; Baena-Cagnani, CE; Bachert, C; Bonini, S; Boulet, LP; Bousquet, PJ; Brozek, JL; Canonica, GW; Casale, TB; Cruz, AA; Fokkens, WJ; Fonseca, JA; van Wijk, RG; Grouse, L; Haahtela, T; Khaltaev, N; Kuna, P; Lockey, RF; Carlsen, KCL; Mullol, J; Naclerio, R; O'Hehir, RE; Ohta, K; Palkonen, S; Papadopoulos, NG; Passalacqua, G; Pawankar, R; Price, D; Ryan, D; Simons, FER; Togias, A; Williams, D; Yorgancioglu, A; Yusuf, OM; Aberer, W; Adachi, M; Agache, I; Aït-Khaled, N; Akdis, CA; Andrianarisoa, A; Annesi-Maesano, I; Ansotegui, IJ; Baiardini, I; Bateman, ED; Bedbrook, A; Beghé, B; Beji, M; Bel, EH; Ben Kheder, A; Bennoor, KS; Bergmann, KC; Berrissoul, F; Bieber, T; Jensen, CB; Blaiss, MS; Boner, AL; Bouchard, J; Braido, F; Brightling, CE; Bush, A; Caballero, F; Calderon, MA; Calvo, MA; Camargos, PAM; Caraballo, LR; Carlsen, KH; Carr, W; Cepeda, AM; Cesario, A; Chavannes, NH; Chen, YZ; Chiriac, AM; Pérez, TC; Chkhartishvili, E; Ciprandi, G; Costa, DJ; Cox, L; Custovic, A; Dahl, R; Darsow, U; De Blay, F; Deleanu, D; Denburg, JA; Devillier, P; Didi, T; Dokic, D; Dolen, WK; Douagui, H; Dubakiene, R; Durham, SR; Dykewicz, MS; El-Gamal, Y; El-Meziane, A; Emuzyte, R; Fiocchi, A; Fletcher, M; Fukuda, T; Gamkrelidze, A; Gereda, JE; Diaz, SG; Gotua, M; Guzmán, MA; Hellings, PW; Hellquist-Dahl, B; Horak, F; Hourihane, JO; Howarth, P; Humbert, M; Ivancevich, JC; Jackson, C; Just, J; Kalayci, O; Kaliner, MA; Kalyoncu, AF; Keil, T; Keith, PK; Khayat, G; Kim, YY; N'Goran, BK; Koppelman, GH; Kowalski, ML; Kull, I; Kvedariene, V; Larenas-Linnemann, D; Le, LT; Lemière, C; Li, J; Lieberman, P; Lipworth, B; Mahboub, B; Makela, MJ; Martin, F; Marshall, GD; Martinez, FD; Masjedi, MR; Maurer, M; Mavale-Manuel, S; Mazon, A; Melen, E; Meltzer, EO; Mendez, NH; Merk, H; Mihaltan, F; Mohammad, Y; Morais-Almeida, M; Muraro, A; Nafti, S; Namazova-Baranova, L; Nekam, K; Neou, A; Niggemann, B; Nizankowska-Mogilnicka, E; Nyembue, TD; Okamoto, Y; Okubo, K; Orru, MP; Ouedraogo, S; Ozdemir, C; Panzner, P; Pali-Schöll, I; Park, HS; Pigearias, B; Pohl, W; Popov, TA; Postma, DS; Potter, P; Rabe, KF; Ratomaharo, J; Reitamo, S; Ring, J; Roberts, R; Rogala, B; Romano, A; Rodriguez, MR; Rosado-Pinto, J; Rosenwasser, L; Rottem, M; Sanchez-Borges, M; Scadding, GK; Schmid-Grendelmeier, P; Sheikh, A; Sisul, JC; Solé, D; Sooronbaev, T; Spicak, V; Spranger, O; Stein, RT; Stoloff, SW; Sunyer, J; Szczeklik, A; Todo-Bom, A; Toskala, E; Tremblay, Y; Valenta, R; Valero, AL; Valeyre, D; Valiulis, A; Valovirta, E; Van Cauwenberge, P; Vandenplas, O; van Weel, C; Vichyanond, P; Viegi, G; Wang, DY; Wickman, M; Wöhrl, S; Wright, J; Yawn, BP; Yiallouros, PK; Zar, HJ; Zernotti, ME; Zhong, N; Zidarn, M; Zuberbier, T
    Allergic rhinitis (AR) and asthma represent global health problems for all age groups. Asthma and rhinitis frequently coexist in the same subjects. Allergic Rhinitis and its Impact on Asthma (ARIA) was initiated during a World Health Organization workshop in 1999 (published in 2001). ARIA has reclassified ARas mild/moderate-severe and intermittent/persistent. This classification closely reflects patients' needs and underlines the close relationship between rhinitis and asthma. Patients, clinicians, and other health care professionals are confronted with various treatment choices for the management of AR. This contributes to considerable variation in clinical practice, and worldwide, patients, clinicians, and other health care professionals are faced with uncertainty about the relative merits and downsides of the various treatment options. In its 2010 Revision, ARIA developed clinical practice guidelines for the management of AR and asthma comorbidities based on the Grading of Recommendation, Assessment, Development and Evaluation (GRADE) system. ARIA is disseminated and implemented in more than 50 countries of the world. Ten years after the publication of the ARIAWorld Health Organization workshop report, it is important to make a summary of its achievements and identify the still unmet clinical, research, and implementation needs to strengthen the 2011 European Union Priority on allergy and asthma in children. (J Allergy Clin Immunol 2012;130:1049-62.)
  • No Thumbnail Available
    Item
    What we should learn from the London Olympics
    Bonini, M; Bachert, C; Baena-Cagnani, CE; Bedbrook, A; Brozek, JL; Canonica, GW; Cruz, AA; Fokkens, WJ; van Wijk, RG; Grouse, L; Hellings, PW; Howarth, P; Kalayci, O; Khaltaev, N; Kuna, P; Linnemann, DL; Nekam, K; Palkonen, S; Papadopoulos, NG; Popov, TA; Price, D; Pinto, JR; Rasi, G; Ryan, D; Samolinski, B; Scadding, GK; Schünemann, HJ; Thomas, DM; Triggiani, M; Yorgancioglu, A; Yusuf, OM; Zuberbier, T; Pawankar, R; Bousquet, J; Bonini, S